Literature DB >> 16167128

High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children.

Kentigern Thorburn1, Nia Taylor, Lucia Lopez-Rodriguez, Michael Ashworth, Miguel Angel de la Cal, Hendrik Karel Ferdinand van Saene.   

Abstract

OBJECTIVE: To ascertain outcome, patterns of disease, incidence of concurrent infection, superinfection and penicillin resistance in children requiring intensive care for Streptococcus pneumoniae infection and compare it to a similar disease pattern, namely Neisseria meningitidis b infection. DESIGN AND
SETTING: Prospective cohort study in a regional paediatric intensive care unit (PICU). PATIENTS AND PARTICIPANTS: Children with invasive pneumococcal and meningococcal disease requiring intensive care. MEASUREMENTS AND
RESULTS: The study included 22 children with invasive pneumococcal disease (IPD), median age 14 months (interquartile range 3-52), median Paediatric Index of Mortality (PIM) 0.051 (0.028-0.066), median length of PICU stay 8.5 days (4-13). Four patients died, three (13.5%) attributable to IPD. Incidence of concurrent infection 27%. There were no superinfections. All S. pneumoniae were sensitive to cefotaxime; one isolate (3.7%) was resistant to penicillin. There were 186 children with meningococcal disease (MD), with a higher PIM (median 0.068, 0.033-0.108), older age (29 months, 10.7-77.9) and shorter length of PICU stay (median 3 days, 2-6). Eight (4.3%) children died from MD. Incidence of concurrent and superinfection was 18% and 6%, respectively in children with MD. All N. meningitidis cases were sensitive to cefotaxime and penicillin. The standardized mortality ratio was considerably higher with IPD (2.0) than with MD (0.52).
CONCLUSIONS: In invasive pneumococcal disease preventative measures including early recognition, immediate antibiotic therapy and vaccination need to be taken in the community, similar to the control of meningococcal disease. Invasive pneumococcal disease should command the same respect as meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16167128     DOI: 10.1007/s00134-005-2803-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  43 in total

Review 1.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

2.  Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era.

Authors:  K A Robinson; W Baughman; G Rothrock; N L Barrett; M Pass; C Lexau; B Damaske; K Stefonek; B Barnes; J Patterson; E R Zell; A Schuchat; C G Whitney
Journal:  JAMA       Date:  2001-04-04       Impact factor: 56.272

3.  The outcome of pediatric intensive care.

Authors:  F Shann; J Carlin
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

4.  Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery.

Authors:  R Booy; P Habibi; S Nadel; C de Munter; J Britto; A Morrison; M Levin
Journal:  Arch Dis Child       Date:  2001-11       Impact factor: 3.791

5.  Early onset pneumococcal sepsis in children hospitalized for noninfectious life-threatening events.

Authors:  P Yagupsky; S Sofer; R Dagan
Journal:  Pediatr Infect Dis J       Date:  2001-11       Impact factor: 2.129

6.  Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.

Authors:  R von Kries; A Siedler; H J Schmitt; R R Reinert
Journal:  Clin Infect Dis       Date:  2000-08-30       Impact factor: 9.079

Review 7.  Pediatric sepsis and multiple organ dysfunction syndrome.

Authors:  O Despond; F Proulx; J A Carcillo; J Lacroix
Journal:  Curr Opin Pediatr       Date:  2001-06       Impact factor: 2.856

8.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Authors:  Cynthia G Whitney; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Ruth Lynfield; Arthur Reingold; Paul R Cieslak; Tamara Pilishvili; Delois Jackson; Richard R Facklam; James H Jorgensen; Anne Schuchat
Journal:  N Engl J Med       Date:  2003-05-01       Impact factor: 91.245

9.  RSV outbreak in a paediatric intensive care unit.

Authors:  K Thorburn; S Kerr; N Taylor; H K F van Saene
Journal:  J Hosp Infect       Date:  2004-07       Impact factor: 3.926

10.  Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Authors:  Sheldon L Kaplan; Edward O Mason; Ellen R Wald; Gordon E Schutze; John S Bradley; Tina Q Tan; Jill A Hoffman; Laurence B Givner; Ram Yogev; William J Barson
Journal:  Pediatrics       Date:  2004-03       Impact factor: 7.124

View more
  1 in total

Review 1.  Year in review in intensive care medicine, 2005. III. Nutrition, pediatric and neonatal critical care, and experimental.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker
Journal:  Intensive Care Med       Date:  2006-02-18       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.